| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | lead ion binding | 3.12e-05 | 3 | 65 | 2 | GO:0032791 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | TFEB FLI1 IRX5 RARA PAX8 YLPM1 DACH1 INSM2 PAX2 PAX5 FOXJ3 MYRF PLSCR1 NOBOX KLF2 | 3.67e-05 | 1412 | 65 | 15 | GO:0000981 |
| GeneOntologyMolecularFunction | transcription coactivator activity | 5.67e-05 | 303 | 65 | 7 | GO:0003713 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | TGFB1I1 ARID1B CITED4 ATN1 ZMIZ2 SMARCA4 INSM2 RUNX1T1 ARID1A | 8.17e-05 | 562 | 65 | 9 | GO:0003712 |
| GeneOntologyMolecularFunction | alpha-actinin binding | 1.39e-04 | 31 | 65 | 3 | GO:0051393 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | TFEB FLI1 IRX5 RARA PAX8 DACH1 SMARCA4 INSM2 PAX2 PAX5 FOXJ3 NOBOX KLF2 | 1.57e-04 | 1244 | 65 | 13 | GO:0000978 |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | TFEB FLI1 IRX5 RARA PAX8 DACH1 SMARCA4 INSM2 PAX2 PAX5 FOXJ3 NOBOX KLF2 | 1.95e-04 | 1271 | 65 | 13 | GO:0000987 |
| GeneOntologyMolecularFunction | mercury ion binding | 2.88e-04 | 8 | 65 | 2 | GO:0045340 | |
| GeneOntologyMolecularFunction | nucleosome binding | 2.94e-04 | 98 | 65 | 4 | GO:0031491 | |
| GeneOntologyMolecularFunction | actinin binding | 3.70e-04 | 43 | 65 | 3 | GO:0042805 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | TFEB FLI1 IRX5 RARA PAX8 DACH1 SMARCA4 INSM2 PAX2 PAX5 FOXJ3 NOBOX KLF2 | 7.33e-04 | 1459 | 65 | 13 | GO:0000977 |
| GeneOntologyMolecularFunction | muscle alpha-actinin binding | 1.07e-03 | 15 | 65 | 2 | GO:0051371 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TGFB1I1 SRRT ARID1B CITED4 ATN1 ZMIZ2 SMARCA4 INSM2 RUNX1T1 ARID1A CRK | 1.20e-03 | 1160 | 65 | 11 | GO:0030674 |
| GeneOntologyMolecularFunction | SH3 domain binding | 1.22e-03 | 143 | 65 | 4 | GO:0017124 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | TGFB1I1 SRRT ARID1B CITED4 ATN1 ZMIZ2 EIF4G1 SMARCA4 INSM2 RUNX1T1 ARID1A CRK | 1.28e-03 | 1356 | 65 | 12 | GO:0060090 |
| GeneOntologyMolecularFunction | protein domain specific binding | 2.02e-03 | 875 | 65 | 9 | GO:0019904 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.24e-03 | 560 | 65 | 7 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.38e-03 | 566 | 65 | 7 | GO:0001216 | |
| GeneOntologyMolecularFunction | phospholipid scramblase activity | 2.53e-03 | 23 | 65 | 2 | GO:0017128 | |
| GeneOntologyMolecularFunction | transcription factor binding | 2.98e-03 | 753 | 65 | 8 | GO:0008134 | |
| GeneOntologyBiologicalProcess | positive regulation of metanephric DCT cell differentiation | 9.78e-06 | 2 | 65 | 2 | GO:2000594 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in metanephric collecting duct development | 9.78e-06 | 2 | 65 | 2 | GO:1900214 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in metanephric collecting duct development | 9.78e-06 | 2 | 65 | 2 | GO:1900215 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in metanephric nephron tubule development | 9.78e-06 | 2 | 65 | 2 | GO:1900218 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in metanephric nephron tubule development | 9.78e-06 | 2 | 65 | 2 | GO:1900217 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 9.78e-06 | 2 | 65 | 2 | GO:1901147 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in metanephric nephron tubule development | 9.78e-06 | 2 | 65 | 2 | GO:1900205 | |
| GeneOntologyBiologicalProcess | apoptotic process involved in metanephric collecting duct development | 9.78e-06 | 2 | 65 | 2 | GO:1900204 | |
| GeneOntologyBiologicalProcess | regulation of metanephric DCT cell differentiation | 9.78e-06 | 2 | 65 | 2 | GO:2000592 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 9.78e-06 | 2 | 65 | 2 | GO:0072305 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in metanephric nephron morphogenesis | 9.78e-06 | 2 | 65 | 2 | GO:0072304 | |
| GeneOntologyBiologicalProcess | kidney field specification | 9.78e-06 | 2 | 65 | 2 | GO:0072004 | |
| GeneOntologyBiologicalProcess | pronephric field specification | 9.78e-06 | 2 | 65 | 2 | GO:0039003 | |
| GeneOntologyBiologicalProcess | pattern specification involved in pronephros development | 9.78e-06 | 2 | 65 | 2 | GO:0039017 | |
| GeneOntologyBiologicalProcess | metanephric DCT cell differentiation | 2.93e-05 | 3 | 65 | 2 | GO:0072240 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in metanephric nephron morphogenesis | 2.93e-05 | 3 | 65 | 2 | GO:0072309 | |
| GeneOntologyBiologicalProcess | kidney rudiment formation | 2.93e-05 | 3 | 65 | 2 | GO:0072003 | |
| GeneOntologyBiologicalProcess | DCT cell differentiation | 2.93e-05 | 3 | 65 | 2 | GO:0072069 | |
| GeneOntologyBiologicalProcess | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 5.84e-05 | 4 | 65 | 2 | GO:0072108 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in metanephros development | 5.84e-05 | 4 | 65 | 2 | GO:1900212 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in metanephros development | 5.84e-05 | 4 | 65 | 2 | GO:1900211 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in nephron morphogenesis | 5.84e-05 | 4 | 65 | 2 | GO:1901145 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule formation | 5.84e-05 | 4 | 65 | 2 | GO:0072289 | |
| GeneOntologyBiologicalProcess | mesenchymal cell apoptotic process involved in metanephros development | 5.84e-05 | 4 | 65 | 2 | GO:1900200 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | 5.84e-05 | 4 | 65 | 2 | GO:0072040 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis | 5.84e-05 | 4 | 65 | 2 | GO:0072039 | |
| GeneOntologyBiologicalProcess | embryonic organ development | 6.29e-05 | 561 | 65 | 9 | GO:0048568 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TFEB FLI1 CCNT2 RARA PAX8 ZMIZ2 SMARCA4 MLLT6 PAX2 PAX5 FOXJ3 PLSCR1 NOBOX KLF2 | 8.81e-05 | 1390 | 65 | 14 | GO:0045944 |
| GeneOntologyBiologicalProcess | metanephric distal convoluted tubule development | 9.72e-05 | 5 | 65 | 2 | GO:0072221 | |
| GeneOntologyBiologicalProcess | metanephric distal tubule development | 9.72e-05 | 5 | 65 | 2 | GO:0072235 | |
| GeneOntologyBiologicalProcess | negative regulation of somatic stem cell population maintenance | 9.72e-05 | 5 | 65 | 2 | GO:1904673 | |
| GeneOntologyBiologicalProcess | distal convoluted tubule development | 9.72e-05 | 5 | 65 | 2 | GO:0072025 | |
| GeneOntologyBiologicalProcess | regulation of nucleotide-excision repair | 1.03e-04 | 29 | 65 | 3 | GO:2000819 | |
| GeneOntologyBiologicalProcess | regulation of stem cell population maintenance | 1.08e-04 | 78 | 65 | 4 | GO:2000036 | |
| GeneOntologyBiologicalProcess | chordate embryonic development | TFEB SEC24D IRX5 RARA MYO1E HCN4 SMARCA4 PAX2 PAX5 ARID1A KLF2 | 1.12e-04 | 906 | 65 | 11 | GO:0043009 |
| GeneOntologyBiologicalProcess | embryo development | TGFB1I1 TFEB COL18A1 SEC24D IRX5 RARA MYO1E HCN4 PAX8 SMARCA4 PAX2 PAX5 ARID1A KLF2 | 1.25e-04 | 1437 | 65 | 14 | GO:0009790 |
| GeneOntologyBiologicalProcess | circulatory system development | COL4A3 COL18A1 ERBB2 LDB3 MIA3 RARA MYO1E HCN4 PAX8 SMARCA4 RAPGEF1 ARID1A PDLIM4 KLF2 | 1.30e-04 | 1442 | 65 | 14 | GO:0072359 |
| GeneOntologyBiologicalProcess | embryo development ending in birth or egg hatching | TFEB SEC24D IRX5 RARA MYO1E HCN4 SMARCA4 PAX2 PAX5 ARID1A KLF2 | 1.40e-04 | 929 | 65 | 11 | GO:0009792 |
| GeneOntologyBiologicalProcess | metanephric tubule formation | 1.45e-04 | 6 | 65 | 2 | GO:0072174 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.80e-04 | 377 | 65 | 7 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.83e-04 | 378 | 65 | 7 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.86e-04 | 379 | 65 | 7 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of epithelial cell differentiation involved in kidney development | 2.03e-04 | 7 | 65 | 2 | GO:2000698 | |
| GeneOntologyBiologicalProcess | metanephric collecting duct development | 2.03e-04 | 7 | 65 | 2 | GO:0072205 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule epithelial cell differentiation | 2.03e-04 | 7 | 65 | 2 | GO:0072257 | |
| GeneOntologyBiologicalProcess | metanephric nephron tubule morphogenesis | 2.03e-04 | 7 | 65 | 2 | GO:0072282 | |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in morphogenesis | 2.03e-04 | 7 | 65 | 2 | GO:1902338 | |
| GeneOntologyBiologicalProcess | regulation of metanephric nephron tubule epithelial cell differentiation | 2.03e-04 | 7 | 65 | 2 | GO:0072307 | |
| GeneOntologyBiologicalProcess | mesenchymal stem cell maintenance involved in nephron morphogenesis | 2.03e-04 | 7 | 65 | 2 | GO:0072038 | |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | TGFB1I1 SRRT FNDC3B ARID1B RARA PAX8 EIF4G1 SMARCA4 PAX2 ARID1A MYRF TNXB | 2.05e-04 | 1141 | 65 | 12 | GO:0045597 |
| GeneOntologyBiologicalProcess | negative regulation of apoptotic process involved in development | 2.70e-04 | 8 | 65 | 2 | GO:1904746 | |
| GeneOntologyBiologicalProcess | pattern specification involved in kidney development | 2.70e-04 | 8 | 65 | 2 | GO:0061004 | |
| GeneOntologyBiologicalProcess | renal system pattern specification | 2.70e-04 | 8 | 65 | 2 | GO:0072048 | |
| GeneOntologyBiologicalProcess | regulation of G0 to G1 transition | 3.14e-04 | 42 | 65 | 3 | GO:0070316 | |
| GeneOntologyBiologicalProcess | mRNA processing | 3.26e-04 | 551 | 65 | 8 | GO:0006397 | |
| GeneOntologyBiologicalProcess | morphogenesis of embryonic epithelium | 3.32e-04 | 190 | 65 | 5 | GO:0016331 | |
| GeneOntologyBiologicalProcess | co-transcriptional mRNA 3'-end processing, cleavage and polyadenylation pathway | 3.47e-04 | 9 | 65 | 2 | GO:0180010 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis | 3.47e-04 | 9 | 65 | 2 | GO:0003339 | |
| GeneOntologyBiologicalProcess | optic cup morphogenesis involved in camera-type eye development | 3.47e-04 | 9 | 65 | 2 | GO:0002072 | |
| GeneOntologyBiologicalProcess | G0 to G1 transition | 3.61e-04 | 44 | 65 | 3 | GO:0045023 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation | TGFB1I1 FNDC3B COL18A1 RARA MYO1E PAX8 SMARCA4 RAPGEF1 PAX2 KLF2 | 3.69e-04 | 870 | 65 | 10 | GO:0030855 |
| GeneOntologyBiologicalProcess | tube development | COL4A3 FNDC3B COL18A1 ERBB2 MIA3 RARA MYO1E PAX8 EIF4G1 SMARCA4 PAX2 ARID1A KLF2 | 3.69e-04 | 1402 | 65 | 13 | GO:0035295 |
| GeneOntologyBiologicalProcess | embryonic camera-type eye development | 3.86e-04 | 45 | 65 | 3 | GO:0031076 | |
| GeneOntologyBiologicalProcess | mRNA 3'-end processing | 4.12e-04 | 46 | 65 | 3 | GO:0031124 | |
| GeneOntologyBiologicalProcess | negative regulation of transcription by RNA polymerase II | ZNF469 RARA ATN1 YLPM1 DACH1 SMARCA4 INSM2 PAX2 PAX5 ARID1A KLF2 | 4.13e-04 | 1053 | 65 | 11 | GO:0000122 |
| GeneOntologyBiologicalProcess | metanephric tubule morphogenesis | 4.33e-04 | 10 | 65 | 2 | GO:0072173 | |
| GeneOntologyBiologicalProcess | co-transcriptional RNA 3'-end processing, cleavage and polyadenylation pathway | 4.33e-04 | 10 | 65 | 2 | GO:0180012 | |
| GeneOntologyBiologicalProcess | glomerular basement membrane development | 4.33e-04 | 10 | 65 | 2 | GO:0032836 | |
| GeneOntologyBiologicalProcess | distal tubule development | 4.33e-04 | 10 | 65 | 2 | GO:0072017 | |
| GeneOntologyBiologicalProcess | pronephros development | 4.33e-04 | 10 | 65 | 2 | GO:0048793 | |
| GeneOntologyBiologicalProcess | epithelial cell differentiation involved in kidney development | 4.39e-04 | 47 | 65 | 3 | GO:0035850 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | 4.54e-04 | 579 | 65 | 8 | GO:0045785 | |
| GeneOntologyBiologicalProcess | cell fate determination | 5.27e-04 | 50 | 65 | 3 | GO:0001709 | |
| GeneOntologyBiologicalProcess | regulation of G1/S transition of mitotic cell cycle | 5.60e-04 | 213 | 65 | 5 | GO:2000045 | |
| GeneOntologyBiologicalProcess | mesenchymal to epithelial transition involved in metanephros morphogenesis | 6.32e-04 | 12 | 65 | 2 | GO:0003337 | |
| GeneOntologyBiologicalProcess | positive regulation of myoblast differentiation | 6.61e-04 | 54 | 65 | 3 | GO:0045663 | |
| GeneOntologyBiologicalProcess | tube morphogenesis | COL4A3 COL18A1 ERBB2 MIA3 RARA MYO1E PAX8 SMARCA4 PAX2 ARID1A KLF2 | 7.18e-04 | 1125 | 65 | 11 | GO:0035239 |
| GeneOntologyBiologicalProcess | regulation of T cell differentiation | 7.31e-04 | 226 | 65 | 5 | GO:0045580 | |
| GeneOntologyBiologicalProcess | regulation of nephron tubule epithelial cell differentiation | 7.46e-04 | 13 | 65 | 2 | GO:0072182 | |
| GeneOntologyBiologicalProcess | negative regulation of mesenchymal cell apoptotic process | 7.46e-04 | 13 | 65 | 2 | GO:2001054 | |
| GeneOntologyBiologicalProcess | embryonic camera-type eye formation | 7.46e-04 | 13 | 65 | 2 | GO:0060900 | |
| GeneOntologyBiologicalProcess | regulation of somatic stem cell population maintenance | 7.46e-04 | 13 | 65 | 2 | GO:1904672 | |
| GeneOntologyBiologicalProcess | collecting duct development | 7.46e-04 | 13 | 65 | 2 | GO:0072044 | |
| GeneOntologyBiologicalProcess | cell differentiation involved in kidney development | 7.74e-04 | 57 | 65 | 3 | GO:0061005 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 8.26e-04 | 351 | 65 | 6 | GO:0048562 | |
| GeneOntologyBiologicalProcess | cellular response to nerve growth factor stimulus | 8.56e-04 | 59 | 65 | 3 | GO:1990090 | |
| GeneOntologyBiologicalProcess | regulation of Fc receptor mediated stimulatory signaling pathway | 8.68e-04 | 14 | 65 | 2 | GO:0060368 | |
| GeneOntologyBiologicalProcess | stem cell population maintenance | 9.05e-04 | 237 | 65 | 5 | GO:0019827 | |
| GeneOntologyBiologicalProcess | response to nerve growth factor | 9.44e-04 | 61 | 65 | 3 | GO:1990089 | |
| GeneOntologyBiologicalProcess | regulation of chromosome segregation | 9.73e-04 | 139 | 65 | 4 | GO:0051983 | |
| GeneOntologyBiologicalProcess | maintenance of cell number | 9.94e-04 | 242 | 65 | 5 | GO:0098727 | |
| GeneOntologyBiologicalProcess | nephron tubule epithelial cell differentiation | 1.00e-03 | 15 | 65 | 2 | GO:0072160 | |
| GeneOntologyBiologicalProcess | metanephric renal vesicle morphogenesis | 1.00e-03 | 15 | 65 | 2 | GO:0072283 | |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in morphogenesis | 1.00e-03 | 15 | 65 | 2 | GO:1902337 | |
| GeneOntologyBiologicalProcess | regulation of cell cycle G1/S phase transition | 1.07e-03 | 246 | 65 | 5 | GO:1902806 | |
| GeneOntologyBiologicalProcess | positive regulation of T cell differentiation | 1.11e-03 | 144 | 65 | 4 | GO:0045582 | |
| GeneOntologyBiologicalProcess | transcription initiation-coupled chromatin remodeling | 1.13e-03 | 65 | 65 | 3 | GO:0045815 | |
| GeneOntologyBiologicalProcess | negative regulation of DNA-templated transcription | ZNF469 RARA ATN1 YLPM1 DACH1 SMARCA4 INSM2 PAX2 PAX5 RUNX1T1 ARID1A KLF2 | 1.27e-03 | 1399 | 65 | 12 | GO:0045892 |
| GeneOntologyBiologicalProcess | regulation of apoptotic process involved in development | 1.29e-03 | 17 | 65 | 2 | GO:1904748 | |
| GeneOntologyBiologicalProcess | regulation of mesenchymal cell apoptotic process | 1.29e-03 | 17 | 65 | 2 | GO:2001053 | |
| GeneOntologyCellularComponent | bBAF complex | 3.39e-06 | 10 | 65 | 3 | GO:0140092 | |
| GeneOntologyCellularComponent | npBAF complex | 1.02e-05 | 14 | 65 | 3 | GO:0071564 | |
| GeneOntologyCellularComponent | nBAF complex | 1.56e-05 | 16 | 65 | 3 | GO:0071565 | |
| GeneOntologyCellularComponent | SWI/SNF complex | 1.10e-04 | 30 | 65 | 3 | GO:0016514 | |
| GeneOntologyCellularComponent | mRNA cleavage factor complex | 1.21e-04 | 31 | 65 | 3 | GO:0005849 | |
| GeneOntologyCellularComponent | chromatin | TFEB FLI1 ARID1B IRX5 RARA PAX8 ZMIZ2 SMARCA4 PAX2 PAX5 ARID1A FOXJ3 NOBOX KLF2 | 1.49e-04 | 1480 | 65 | 14 | GO:0000785 |
| GeneOntologyCellularComponent | transcription regulator complex | 5.03e-04 | 596 | 65 | 8 | GO:0005667 | |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | CCNT2 ERBB2 LDB3 RARA ATN1 HCN4 RAPGEF1 ZDHHC8 PLSCR1 PDLIM4 | 5.80e-04 | 934 | 65 | 10 | GO:0048471 |
| GeneOntologyCellularComponent | brahma complex | 8.46e-04 | 14 | 65 | 2 | GO:0035060 | |
| GeneOntologyCellularComponent | nuclear matrix | 9.51e-04 | 140 | 65 | 4 | GO:0016363 | |
| GeneOntologyCellularComponent | nuclear periphery | 1.99e-03 | 171 | 65 | 4 | GO:0034399 | |
| HumanPheno | Hypoplastic fifth fingernail | 5.79e-05 | 14 | 29 | 3 | HP:0008398 | |
| HumanPheno | Short phalanx of the 5th toe | 9.36e-05 | 3 | 29 | 2 | HP:0100368 | |
| HumanPheno | Soft skin | 9.83e-05 | 44 | 29 | 4 | HP:0000977 | |
| HumanPheno | Prominent eyelashes | 1.07e-04 | 17 | 29 | 3 | HP:0011231 | |
| HumanPheno | Oral aversion | 1.07e-04 | 17 | 29 | 3 | HP:0012523 | |
| HumanPheno | Hypoplastic fifth toenail | 1.51e-04 | 19 | 29 | 3 | HP:0011937 | |
| HumanPheno | Aplasia/Hypoplasia of the 5th toe | 1.86e-04 | 4 | 29 | 2 | HP:0010343 | |
| MousePheno | hemorrhage | COL4A3 FLI1 COL18A1 ERBB2 MIA3 MYO1E SZT2 RAPGEF1 RUNX1T1 ARID1A CRK KLF2 | 1.71e-05 | 664 | 59 | 12 | MP:0001914 |
| MousePheno | absent uterine horn | 1.75e-05 | 2 | 59 | 2 | MP:0009215 | |
| MousePheno | abnormal blood vessel morphology | PIGQ COL4A3 FLI1 CCNT2 COL18A1 ERBB2 LDB3 ARID1B MYO1E PAX8 EIF4G1 SMARCA4 CSTF3 RAPGEF1 PAX2 ARID1A CRK KLF2 | 2.17e-05 | 1472 | 59 | 18 | MP:0001614 |
| MousePheno | absent efferent ductules of testis | 5.24e-05 | 3 | 59 | 2 | MP:0004729 | |
| Domain | Pax2_C | 3.48e-08 | 3 | 62 | 3 | IPR022130 | |
| Domain | Pax2_C | 3.48e-08 | 3 | 62 | 3 | PF12403 | |
| Domain | PAX | 2.88e-06 | 9 | 62 | 3 | SM00351 | |
| Domain | Paired_dom | 2.88e-06 | 9 | 62 | 3 | IPR001523 | |
| Domain | PAIRED_2 | 2.88e-06 | 9 | 62 | 3 | PS51057 | |
| Domain | PAX | 2.88e-06 | 9 | 62 | 3 | PF00292 | |
| Domain | PAIRED_1 | 2.88e-06 | 9 | 62 | 3 | PS00034 | |
| Domain | BAF250_C | 1.08e-05 | 2 | 62 | 2 | IPR033388 | |
| Domain | BAF250_C | 1.08e-05 | 2 | 62 | 2 | PF12031 | |
| Domain | BAF250/Osa | 1.08e-05 | 2 | 62 | 2 | IPR021906 | |
| Domain | SH3 | 8.00e-05 | 216 | 62 | 6 | SM00326 | |
| Domain | SH3 | 8.00e-05 | 216 | 62 | 6 | PS50002 | |
| Domain | SH3_domain | 8.85e-05 | 220 | 62 | 6 | IPR001452 | |
| Domain | Scramblase | 1.08e-04 | 5 | 62 | 2 | PF03803 | |
| Domain | Scramblase | 1.08e-04 | 5 | 62 | 2 | IPR005552 | |
| Domain | DUF4749 | 1.61e-04 | 6 | 62 | 2 | PF15936 | |
| Domain | DUF4749 | 1.61e-04 | 6 | 62 | 2 | IPR031847 | |
| Domain | - | 7.80e-04 | 218 | 62 | 5 | 1.10.10.10 | |
| Domain | - | 1.11e-03 | 15 | 62 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 1.11e-03 | 15 | 62 | 2 | SM00501 | |
| Domain | ARID_dom | 1.11e-03 | 15 | 62 | 2 | IPR001606 | |
| Domain | ARID | 1.11e-03 | 15 | 62 | 2 | PS51011 | |
| Domain | ARID | 1.11e-03 | 15 | 62 | 2 | PF01388 | |
| Domain | WHTH_DNA-bd_dom | 1.24e-03 | 242 | 62 | 5 | IPR011991 | |
| Domain | LIM | 1.56e-03 | 69 | 62 | 3 | PF00412 | |
| Domain | - | 1.63e-03 | 70 | 62 | 3 | 2.10.110.10 | |
| Domain | Znf_LIM | 1.70e-03 | 71 | 62 | 3 | IPR001781 | |
| Domain | LIM_DOMAIN_1 | 1.70e-03 | 71 | 62 | 3 | PS00478 | |
| Domain | LIM_DOMAIN_2 | 1.70e-03 | 71 | 62 | 3 | PS50023 | |
| Domain | LIM | 1.70e-03 | 71 | 62 | 3 | SM00132 | |
| Domain | SH3_1 | 2.15e-03 | 164 | 62 | 4 | PF00018 | |
| Domain | SH3_2 | 2.93e-03 | 86 | 62 | 3 | IPR011511 | |
| Domain | SH3_2 | 2.93e-03 | 86 | 62 | 3 | PF07653 | |
| Domain | Homeodomain-like | 4.87e-03 | 332 | 62 | 5 | IPR009057 | |
| Pathway | WP_ID_SIGNALING | 2.28e-05 | 16 | 50 | 3 | M39359 | |
| Pathway | WP_ANDROGEN_RECEPTOR_NETWORK_IN_PROSTATE_CANCER | 4.23e-05 | 110 | 50 | 5 | M48043 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 4.59e-05 | 20 | 50 | 3 | M497 | |
| Pathway | REACTOME_PROCESSING_OF_INTRONLESS_PRE_MRNAS | 4.59e-05 | 20 | 50 | 3 | MM15469 | |
| Pathway | WP_KLEEFSTRA_SYNDROME | 1.44e-04 | 29 | 50 | 3 | M48076 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.44e-04 | 29 | 50 | 3 | M783 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRONLESS_PRE_MRNA | 1.44e-04 | 29 | 50 | 3 | MM15444 | |
| Pathway | WP_TUMOR_SUPPRESSOR_ACTIVITY_OF_SMARCB1 | 1.76e-04 | 31 | 50 | 3 | M39522 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY | 2.54e-04 | 35 | 50 | 3 | M47969 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 3.00e-04 | 37 | 50 | 3 | M27797 | |
| Pathway | REACTOME_FORMATION_OF_INTERMEDIATE_MESODERM | 3.41e-04 | 8 | 50 | 2 | M48014 | |
| Pathway | REACTOME_REGULATION_OF_MITF_M_DEPENDENT_GENES_INVOLVED_IN_PIGMENTATION | 4.37e-04 | 42 | 50 | 3 | M48237 | |
| Pathway | WP_NEPHROTIC_SYNDROME | 5.36e-04 | 45 | 50 | 3 | M39864 | |
| Pathway | BIOCARTA_CPSF_PATHWAY | 5.45e-04 | 10 | 50 | 2 | M22041 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 5.45e-04 | 10 | 50 | 2 | MM1532 | |
| Pathway | REACTOME_MET_ACTIVATES_RAP1_AND_RAC1 | 6.64e-04 | 11 | 50 | 2 | M27776 | |
| Pathway | REACTOME_MET_ACTIVATES_RAP1_AND_RAC1 | 6.64e-04 | 11 | 50 | 2 | MM15515 | |
| Pathway | WP_ID_SIGNALING_PATHWAY | 7.32e-04 | 50 | 50 | 3 | MM15817 | |
| Pathway | BIOCARTA_HSWI_SNF_PATHWAY | 7.95e-04 | 12 | 50 | 2 | M22006 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.07e-03 | 57 | 50 | 3 | MM14713 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 1.09e-03 | 14 | 50 | 2 | M622 | |
| Pathway | REACTOME_PROLONGED_ERK_ACTIVATION_EVENTS | 1.09e-03 | 14 | 50 | 2 | MM14667 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 1.13e-03 | 58 | 50 | 3 | M2049 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | COL4A3 TFEB FLI1 CACNB1 ERBB2 ARID1B RARA PAX8 EIF4G1 SMARCA4 PAX2 ARID1A NOBOX | 1.14e-03 | 1432 | 50 | 13 | M509 |
| Pathway | WP_PREIMPLANTATION_EMBRYO | 1.19e-03 | 59 | 50 | 3 | M39579 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.37e-03 | 62 | 50 | 3 | MM15426 | |
| Pathway | REACTOME_MITF_M_REGULATED_MELANOCYTE_DEVELOPMENT | 1.39e-03 | 137 | 50 | 4 | M48232 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION_TERMINATION | 1.71e-03 | 67 | 50 | 3 | M27694 | |
| Pathway | REACTOME_FORMATION_OF_THE_NEPHRIC_DUCT | 1.82e-03 | 18 | 50 | 2 | M48242 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.11e-03 | 72 | 50 | 3 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 2.19e-03 | 73 | 50 | 3 | MM15906 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 2.48e-03 | 21 | 50 | 2 | MM15633 | |
| Pathway | REACTOME_RMTS_METHYLATE_HISTONE_ARGININES | 2.65e-03 | 78 | 50 | 3 | M27234 | |
| Pathway | PID_PDGFRA_PATHWAY | 2.72e-03 | 22 | 50 | 2 | M206 | |
| Pathway | REACTOME_REGULATION_OF_SIGNALING_BY_CBL | 2.72e-03 | 22 | 50 | 2 | M903 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 2.72e-03 | 22 | 50 | 2 | MM1370 | |
| Pathway | REACTOME_GENE_EXPRESSION_TRANSCRIPTION | SRRT CCNT2 CITED4 RARA SMARCA4 CSTF2 CSTF3 PAX5 ARID1A CPSF7 | 2.74e-03 | 1022 | 50 | 10 | MM15436 |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | SRRT CCNT2 ERBB2 ARID1B CITED4 RARA SMARCA4 CSTF2 CSTF3 PAX5 ARID1A CPSF7 | 2.76e-03 | 1387 | 50 | 12 | M734 |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 2.91e-03 | 277 | 50 | 5 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 3.19e-03 | 283 | 50 | 5 | M13087 | |
| Pathway | BIOCARTA_VDR_PATHWAY | 3.24e-03 | 24 | 50 | 2 | M13404 | |
| Pubmed | MIA3 RARA ATN1 DAZAP1 YLPM1 SMARCA4 CSTF2 CSTF3 DIDO1 HNRNPUL1 KHSRP CPSF7 | 1.11e-14 | 220 | 66 | 12 | 24550385 | |
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | SRRT ARID1B DAZAP1 YLPM1 CSTF3 DIDO1 HNRNPUL1 ARID1A PLRG1 KHSRP CPSF7 | 4.00e-13 | 220 | 66 | 11 | 35785414 |
| Pubmed | FLI1 CCNT2 ARID1B RARA DAZAP1 ZMIZ2 DACH1 SMARCA4 CSTF3 C15orf39 DIDO1 MLLT6 HNRNPUL1 ARID1A FOXJ3 PLRG1 KHSRP CPSF7 | 1.50e-12 | 1103 | 66 | 18 | 34189442 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SRRT ARID1B RARA DAZAP1 YLPM1 EIF4G1 DACH1 SMARCA4 CSTF2 CSTF3 DIDO1 MLLT6 HNRNPUL1 ARID1A PLRG1 KHSRP CPSF7 | 1.75e-12 | 954 | 66 | 17 | 36373674 |
| Pubmed | FLI1 SRRT ARID1B ATN1 PAX8 ZMIZ2 YLPM1 EIF4G1 DACH1 SMARCA4 CSTF2 C15orf39 DIDO1 MLLT6 PAX2 HNRNPUL1 ARID1A CPSF7 | 1.05e-10 | 1429 | 66 | 18 | 35140242 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | SRRT CCNT2 ARID1B YLPM1 EIF4G1 SMARCA4 CSTF2 CSTF3 DIDO1 HNRNPUL1 ARID1A PLRG1 TNXB KHSRP CPSF7 | 1.37e-09 | 1082 | 66 | 15 | 38697112 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TFEB ERBB2 MYO1E SZT2 ZMIZ2 CASKIN1 EIF4G1 KBTBD11 C15orf39 RAPGEF1 MLLT6 PAX2 ARID1A ZDHHC8 MYRF | 1.82e-09 | 1105 | 66 | 15 | 35748872 |
| Pubmed | PAX immunoreactivity in poorly differentiated small round cell tumors of childhood. | 6.53e-09 | 3 | 66 | 3 | 24897005 | |
| Pubmed | Pax-5 is expressed at the midbrain-hindbrain boundary during mouse development. | 6.53e-09 | 3 | 66 | 3 | 1283313 | |
| Pubmed | Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. | 6.53e-09 | 3 | 66 | 3 | 22426308 | |
| Pubmed | SRRT MIA3 ATN1 DAZAP1 DACH1 CSTF2 C15orf39 ARID1A PDLIM4 CPSF7 | 7.66e-09 | 425 | 66 | 10 | 24999758 | |
| Pubmed | LDB3 CITED4 RARA ZMIZ2 SMARCA4 DIDO1 PAX2 PAX5 ARID1A FOXJ3 PDLIM4 KLF2 | 8.46e-09 | 709 | 66 | 12 | 22988430 | |
| Pubmed | Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding. | 2.61e-08 | 4 | 66 | 3 | 11134340 | |
| Pubmed | Cloning and characterization of hELD/OSA1, a novel BRG1 interacting protein. | 2.61e-08 | 4 | 66 | 3 | 11988099 | |
| Pubmed | 2.61e-08 | 4 | 66 | 3 | 28863077 | ||
| Pubmed | Two Pax-binding sites are required for early embryonic brain expression of an Engrailed-2 transgene. | 2.61e-08 | 4 | 66 | 3 | 8625814 | |
| Pubmed | Two related ARID family proteins are alternative subunits of human SWI/SNF complexes. | 2.61e-08 | 4 | 66 | 3 | 15170388 | |
| Pubmed | TFEB CITED4 RARA ZMIZ2 DIDO1 MLLT6 PAX2 HNRNPUL1 ARID1A FOXJ3 NOBOX KLF2 | 3.56e-08 | 808 | 66 | 12 | 20412781 | |
| Pubmed | 6.51e-08 | 5 | 66 | 3 | 12200431 | ||
| Pubmed | ARID1B YLPM1 DACH1 SMARCA4 CSTF2 PTPN23 DIDO1 ARID1A CRK KHSRP | 8.46e-08 | 549 | 66 | 10 | 38280479 | |
| Pubmed | FET family fusion oncoproteins target the SWI/SNF chromatin remodeling complex. | 1.02e-07 | 23 | 66 | 4 | 30962207 | |
| Pubmed | Roles of Pax-genes in developing and adult brain as suggested by expression patterns. | 1.30e-07 | 6 | 66 | 3 | 8126546 | |
| Pubmed | 1.30e-07 | 6 | 66 | 3 | 16230384 | ||
| Pubmed | Numerous BAF complex genes are mutated in Coffin-Siris syndrome. | 1.30e-07 | 6 | 66 | 3 | 25081545 | |
| Pubmed | Mapping of the human homologs of the murine paired-box-containing genes. | 1.30e-07 | 6 | 66 | 3 | 8431641 | |
| Pubmed | TGFB1I1 CACNB1 RARA ATN1 CSTF2 MLLT6 RUNX1T1 PLSCR1 CRK CPSF7 | 2.17e-07 | 608 | 66 | 10 | 16713569 | |
| Pubmed | 2.27e-07 | 7 | 66 | 3 | 23540691 | ||
| Pubmed | 2.34e-07 | 28 | 66 | 4 | 30037996 | ||
| Pubmed | Menin and Menin-Associated Proteins Coregulate Cancer Energy Metabolism. | 2.76e-07 | 341 | 66 | 8 | 32971831 | |
| Pubmed | Distinct regulators control the expression of the mid-hindbrain organizer signal FGF8. | 3.63e-07 | 8 | 66 | 3 | 11704761 | |
| Pubmed | SRRT CCNT2 YLPM1 EIF4G1 SMARCA4 CSTF2 CSTF3 DIDO1 PLRG1 CRK KHSRP CPSF7 | 4.09e-07 | 1014 | 66 | 12 | 32416067 | |
| Pubmed | 4.80e-07 | 153 | 66 | 6 | 28225217 | ||
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | SRRT DAZAP1 EIF4G1 SMARCA4 CSTF2 PTPN23 ARID1A PLRG1 CRK KHSRP | 4.92e-07 | 665 | 66 | 10 | 30457570 |
| Pubmed | WW domains provide a platform for the assembly of multiprotein networks. | 4.99e-07 | 154 | 66 | 6 | 16055720 | |
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 23556151 | ||
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 37805104 | ||
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 7883790 | ||
| Pubmed | 5.44e-07 | 9 | 66 | 3 | 10197584 | ||
| Pubmed | Mammalian SWI/SNF--a subunit BAF250/ARID1 is an E3 ubiquitin ligase that targets histone H2B. | 5.44e-07 | 9 | 66 | 3 | 20086098 | |
| Pubmed | Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9. | 5.44e-07 | 9 | 66 | 3 | 7981748 | |
| Pubmed | A protein-RNA interaction atlas of the ribosome biogenesis factor AATF. | 6.71e-07 | 162 | 66 | 6 | 31363146 | |
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | TGFB1I1 FLI1 CITED4 RARA PAX8 DACH1 INSM2 HNRNPUL1 RUNX1T1 PLRG1 PDLIM4 | 7.47e-07 | 877 | 66 | 11 | 20211142 |
| Pubmed | ARID1a-DNA interactions are required for promoter occupancy by SWI/SNF. | 7.76e-07 | 10 | 66 | 3 | 23129809 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.05e-06 | 908 | 66 | 11 | 19274049 | |
| Pubmed | Pax3 Hypomorphs Reveal Hidden Pax7 Functional Genetic Compensation in Utero. | 1.07e-06 | 11 | 66 | 3 | 35645295 | |
| Pubmed | Histone-binding of DPF2 mediates its repressive role in myeloid differentiation. | 1.13e-06 | 283 | 66 | 7 | 28533407 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | SRRT COL18A1 ARID1B YLPM1 EIF4G1 DACH1 CSTF2 CSTF3 HNRNPUL1 KHSRP CPSF7 | 1.22e-06 | 922 | 66 | 11 | 27609421 |
| Pubmed | 1.42e-06 | 12 | 66 | 3 | 11734557 | ||
| Pubmed | Combinatorial CRISPR screen identifies fitness effects of gene paralogues. | 1.50e-06 | 186 | 66 | 6 | 33637726 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 1.57e-06 | 430 | 66 | 8 | 35044719 | |
| Pubmed | 1.82e-06 | 46 | 66 | 4 | 20301533 | ||
| Pubmed | 1.84e-06 | 13 | 66 | 3 | 17166926 | ||
| Pubmed | 1.84e-06 | 13 | 66 | 3 | 17340523 | ||
| Pubmed | ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. | 2.31e-06 | 315 | 66 | 7 | 26777405 | |
| Pubmed | 2.31e-06 | 453 | 66 | 8 | 29656893 | ||
| Pubmed | 2.34e-06 | 14 | 66 | 3 | 12438746 | ||
| Pubmed | Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation. | 2.46e-06 | 457 | 66 | 8 | 32344865 | |
| Pubmed | 2.64e-06 | 114 | 66 | 5 | 31553912 | ||
| Pubmed | 2.92e-06 | 15 | 66 | 3 | 23785148 | ||
| Pubmed | Mammalian SWI/SNF complexes promote MyoD-mediated muscle differentiation. | 2.92e-06 | 15 | 66 | 3 | 11175787 | |
| Pubmed | Regulation of dendritic development by neuron-specific chromatin remodeling complexes. | 2.92e-06 | 15 | 66 | 3 | 17920018 | |
| Pubmed | Distinct mammalian SWI/SNF chromatin remodeling complexes with opposing roles in cell-cycle control. | 2.92e-06 | 15 | 66 | 3 | 17255939 | |
| Pubmed | Pax: a murine multigene family of paired box-containing genes. | 2.92e-06 | 15 | 66 | 3 | 1685142 | |
| Pubmed | 2.92e-06 | 15 | 66 | 3 | 11263494 | ||
| Pubmed | PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis. | 3.55e-06 | 2 | 66 | 2 | 35387670 | |
| Pubmed | Mobilization of pro-inflammatory lipids in obese Plscr3-deficient mice. | 3.55e-06 | 2 | 66 | 2 | 17355638 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 31141251 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 21934480 | ||
| Pubmed | Functional heterogeneity of PAX5 chimeras reveals insight for leukemia development. | 3.55e-06 | 2 | 66 | 2 | 24435167 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 10973986 | ||
| Pubmed | Dissecting the role of SWI/SNF component ARID1B in steady-state hematopoiesis. | 3.55e-06 | 2 | 66 | 2 | 37611161 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 23328975 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 32791957 | ||
| Pubmed | Insulin and EGF receptors integrate the Ras and Rap signaling pathways. | 3.55e-06 | 2 | 66 | 2 | 12054111 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 8413205 | ||
| Pubmed | PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison. | 3.55e-06 | 2 | 66 | 2 | 23194047 | |
| Pubmed | Pax8, a murine paired box gene expressed in the developing excretory system and thyroid gland. | 3.55e-06 | 2 | 66 | 2 | 1723950 | |
| Pubmed | Chromatin accessibility underlies synthetic lethality of SWI/SNF subunits in ARID1A-mutant cancers. | 3.55e-06 | 2 | 66 | 2 | 28967863 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 30257008 | ||
| Pubmed | Paired box genes, PAX-2 and PAX-8, are not frequently mutated in Wilms tumor. | 3.55e-06 | 2 | 66 | 2 | 16814811 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 19887456 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 26823795 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 34386776 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 23202128 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 22807381 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 33890484 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 21989345 | ||
| Pubmed | A subset of solitary fibrous tumors express nuclear PAX8 and PAX2: a potential diagnostic pitfall. | 3.55e-06 | 2 | 66 | 2 | 26404914 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 34997313 | ||
| Pubmed | Crk interacts with tyrosine-phosphorylated p116 upon T cell activation. | 3.55e-06 | 2 | 66 | 2 | 7531694 | |
| Pubmed | ARID1B is a specific vulnerability in ARID1A-mutant cancers. | 3.55e-06 | 2 | 66 | 2 | 24562383 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 25500505 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 1337742 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 15328404 | ||
| Pubmed | Interactions of CstF-64, CstF-77, and symplekin: implications on localisation and function. | 3.55e-06 | 2 | 66 | 2 | 21119002 | |
| Pubmed | PAX8 and PAX2 expression in endocervical adenocarcinoma in situ and high-grade squamous dysplasia. | 3.55e-06 | 2 | 66 | 2 | 23202787 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 21836481 | ||
| Pubmed | ARID1B as a Potential Therapeutic Target for ARID1A-Mutant Ovarian Clear Cell Carcinoma. | 3.55e-06 | 2 | 66 | 2 | 29890703 | |
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 37977366 | ||
| Pubmed | 3.55e-06 | 2 | 66 | 2 | 10662641 | ||
| Interaction | SNRNP40 interactions | SRRT CCNT2 ARID1B RARA ATN1 DAZAP1 MYO1E ZMIZ2 SMARCA4 CSTF3 MLLT6 HNRNPUL1 ARID1A PLRG1 KHSRP CPSF7 | 1.27e-10 | 637 | 65 | 16 | int:SNRNP40 |
| Interaction | TLE3 interactions | SRRT ARID1B ATN1 PAX8 ZMIZ2 SMARCA4 CSTF2 C15orf39 MLLT6 PAX2 ARID1A CPSF7 | 2.47e-09 | 376 | 65 | 12 | int:TLE3 |
| Interaction | EWSR1 interactions | FLI1 SRRT SEC24D MIA3 RARA ATN1 DAZAP1 PRR13 DACH1 SMARCA4 CSTF2 C15orf39 HNRNPUL1 ARID1A PLSCR1 PDLIM4 CPSF7 | 2.63e-09 | 906 | 65 | 17 | int:EWSR1 |
| Interaction | WWOX interactions | MIA3 RARA ATN1 DAZAP1 YLPM1 SMARCA4 CSTF2 CSTF3 SMR3A DIDO1 PLSCR3 HNRNPUL1 KHSRP CPSF7 | 9.72e-09 | 627 | 65 | 14 | int:WWOX |
| Interaction | SMC5 interactions | SRRT ARID1B RARA DAZAP1 YLPM1 EIF4G1 DACH1 SMARCA4 CSTF2 CSTF3 DIDO1 MLLT6 HNRNPUL1 ARID1A PLRG1 KHSRP CPSF7 | 1.15e-08 | 1000 | 65 | 17 | int:SMC5 |
| Interaction | PRMT2 interactions | 1.70e-08 | 91 | 65 | 7 | int:PRMT2 | |
| Interaction | SS18L1 interactions | 2.86e-08 | 98 | 65 | 7 | int:SS18L1 | |
| Interaction | SP7 interactions | FLI1 SRRT ARID1B ATN1 ZMIZ2 YLPM1 SMARCA4 C15orf39 ARID1A CPSF7 | 4.53e-08 | 304 | 65 | 10 | int:SP7 |
| Interaction | CEBPA interactions | FLI1 CCNT2 ARID1B RARA DAZAP1 ZMIZ2 DACH1 SMARCA4 CSTF3 C15orf39 DIDO1 MLLT6 HNRNPUL1 ARID1A FOXJ3 PLRG1 KHSRP CPSF7 | 4.70e-08 | 1245 | 65 | 18 | int:CEBPA |
| Interaction | AR interactions | TGFB1I1 SRRT ARID1B ATN1 DAZAP1 ZMIZ2 YLPM1 SMARCA4 CSTF3 DIDO1 HNRNPUL1 ARID1A PLRG1 CRK KHSRP CPSF7 | 7.01e-08 | 992 | 65 | 16 | int:AR |
| Interaction | WWP2 interactions | SEC24D ARID1B ATN1 DAZAP1 YLPM1 EIF4G1 SMARCA4 SMR3A DIDO1 HNRNPUL1 ARID1A PLRG1 KHSRP CPSF7 | 3.61e-07 | 840 | 65 | 14 | int:WWP2 |
| Interaction | CPSF6 interactions | SRRT YLPM1 EIF4G1 CSTF2 CSTF3 DIDO1 HNRNPUL1 PLRG1 PLSCR1 KHSRP CPSF7 | 8.63e-07 | 526 | 65 | 11 | int:CPSF6 |
| Interaction | EP300 interactions | TGFB1I1 SRRT ZNF469 CITED4 RARA PAX8 YLPM1 SMARCA4 CSTF3 PAX5 HNRNPUL1 ARID1A PLRG1 PLSCR1 KHSRP CPSF7 KLF2 | 1.43e-06 | 1401 | 65 | 17 | int:EP300 |
| Interaction | YAP1 interactions | TGFB1I1 TFEB COL18A1 ARID1B ATN1 YLPM1 DACH1 SMARCA4 DIDO1 HNRNPUL1 ARID1A FOXJ3 CRK KHSRP CPSF7 | 1.54e-06 | 1095 | 65 | 15 | int:YAP1 |
| Interaction | PAX8 interactions | 1.55e-06 | 111 | 65 | 6 | int:PAX8 | |
| Interaction | CRX interactions | 1.55e-06 | 254 | 65 | 8 | int:CRX | |
| Interaction | MLLT1 interactions | 2.81e-06 | 123 | 65 | 6 | int:MLLT1 | |
| Interaction | ETV4 interactions | 2.86e-06 | 69 | 65 | 5 | int:ETV4 | |
| Interaction | PAX9 interactions | 3.88e-06 | 130 | 65 | 6 | int:PAX9 | |
| Interaction | ATXN1 interactions | SRRT DAZAP1 PAX8 EIF4G1 SMARCA4 CSTF2 RAPGEF1 PTPN23 PAX2 ARID1A PLRG1 CRK KHSRP CPSF7 | 4.45e-06 | 1039 | 65 | 14 | int:ATXN1 |
| Interaction | FUS interactions | FLI1 SRRT FNDC3B COL18A1 RARA YLPM1 SMARCA4 CSTF2 DIDO1 HNRNPUL1 ARID1A PLRG1 | 4.67e-06 | 757 | 65 | 12 | int:FUS |
| Interaction | SOX7 interactions | 6.72e-06 | 82 | 65 | 5 | int:SOX7 | |
| Interaction | RUNX1 interactions | 9.32e-06 | 324 | 65 | 8 | int:RUNX1 | |
| Interaction | DTX2 interactions | 1.06e-05 | 330 | 65 | 8 | int:DTX2 | |
| Interaction | MECP2 interactions | SRRT CCNT2 ARID1B YLPM1 EIF4G1 SMARCA4 CSTF2 CSTF3 DIDO1 HNRNPUL1 ARID1A PLRG1 TNXB KHSRP CPSF7 | 1.11e-05 | 1287 | 65 | 15 | int:MECP2 |
| Interaction | SMAD3 interactions | 1.28e-05 | 447 | 65 | 9 | int:SMAD3 | |
| Interaction | DPF1 interactions | 1.38e-05 | 95 | 65 | 5 | int:DPF1 | |
| Interaction | EGR2 interactions | 1.87e-05 | 171 | 65 | 6 | int:EGR2 | |
| Interaction | CREBBP interactions | ARID1B CITED4 RARA MYO1E PAX8 DACH1 SMARCA4 PAX5 ARID1A KLF2 | 2.05e-05 | 599 | 65 | 10 | int:CREBBP |
| Interaction | ARID1B interactions | 2.27e-05 | 177 | 65 | 6 | int:ARID1B | |
| Interaction | SMARCD3 interactions | 2.46e-05 | 107 | 65 | 5 | int:SMARCD3 | |
| Interaction | ALG13 interactions | 2.74e-05 | 183 | 65 | 6 | int:ALG13 | |
| Interaction | SMARCC1 interactions | 3.16e-05 | 384 | 65 | 8 | int:SMARCC1 | |
| Interaction | HNF1B interactions | 3.38e-05 | 190 | 65 | 6 | int:HNF1B | |
| Interaction | ETS1 interactions | 4.45e-05 | 121 | 65 | 5 | int:ETS1 | |
| Interaction | BMI1 interactions | SRRT DAZAP1 YLPM1 EIF4G1 SMARCA4 DIDO1 HNRNPUL1 PLRG1 KHSRP CPSF7 | 4.61e-05 | 659 | 65 | 10 | int:BMI1 |
| Interaction | FLI1 interactions | 4.78e-05 | 62 | 65 | 4 | int:FLI1 | |
| Interaction | TOP3B interactions | TFEB ERBB2 MYO1E SZT2 ZMIZ2 CASKIN1 EIF4G1 KBTBD11 C15orf39 RAPGEF1 MLLT6 PAX2 ARID1A ZDHHC8 MYRF | 5.25e-05 | 1470 | 65 | 15 | int:TOP3B |
| Interaction | FMR1 interactions | CACNB1 MIA3 DAZAP1 CASKIN1 IQSEC2 EIF4G1 SMARCA4 PLRG1 KHSRP | 5.29e-05 | 536 | 65 | 9 | int:FMR1 |
| Interaction | PCGF1 interactions | 5.60e-05 | 208 | 65 | 6 | int:PCGF1 | |
| Interaction | FUBP1 interactions | 6.05e-05 | 309 | 65 | 7 | int:FUBP1 | |
| Interaction | NUP35 interactions | 6.35e-05 | 424 | 65 | 8 | int:NUP35 | |
| Interaction | BICRA interactions | 6.48e-05 | 67 | 65 | 4 | int:BICRA | |
| Interaction | TOP1 interactions | SRRT ERBB2 YLPM1 SMARCA4 CSTF2 CSTF3 DIDO1 ARID1A PLRG1 CPSF7 | 7.28e-05 | 696 | 65 | 10 | int:TOP1 |
| Interaction | SMG7 interactions | 7.39e-05 | 319 | 65 | 7 | int:SMG7 | |
| Interaction | ERG interactions | 8.22e-05 | 223 | 65 | 6 | int:ERG | |
| Interaction | SOX15 interactions | 9.20e-05 | 141 | 65 | 5 | int:SOX15 | |
| Interaction | MEN1 interactions | SRRT ARID1B ATN1 YLPM1 EIF4G1 SMARCA4 CSTF3 DIDO1 ARID1A PLRG1 CRK KHSRP | 9.66e-05 | 1029 | 65 | 12 | int:MEN1 |
| Interaction | DAZL interactions | 1.05e-04 | 145 | 65 | 5 | int:DAZL | |
| Interaction | DPF2 interactions | 1.29e-04 | 349 | 65 | 7 | int:DPF2 | |
| Interaction | ITCH interactions | 1.46e-04 | 356 | 65 | 7 | int:ITCH | |
| Interaction | SNRPA interactions | 1.54e-04 | 482 | 65 | 8 | int:SNRPA | |
| Interaction | NCOR1 interactions | 1.65e-04 | 363 | 65 | 7 | int:NCOR1 | |
| Interaction | NUP43 interactions | 1.70e-04 | 625 | 65 | 9 | int:NUP43 | |
| Interaction | CPSF1 interactions | 1.71e-04 | 255 | 65 | 6 | int:CPSF1 | |
| Interaction | GSC interactions | 1.79e-04 | 87 | 65 | 4 | int:GSC | |
| Interaction | SS18 interactions | 1.88e-04 | 88 | 65 | 4 | int:SS18 | |
| Interaction | LGR4 interactions | 1.98e-04 | 262 | 65 | 6 | int:LGR4 | |
| Interaction | ESRRB interactions | 1.98e-04 | 262 | 65 | 6 | int:ESRRB | |
| Interaction | HOXB2 interactions | 2.12e-04 | 36 | 65 | 3 | int:HOXB2 | |
| Interaction | TNIP2 interactions | SRRT COL18A1 ARID1B YLPM1 EIF4G1 DACH1 CSTF2 CSTF3 HNRNPUL1 KHSRP CPSF7 | 2.12e-04 | 952 | 65 | 11 | int:TNIP2 |
| Interaction | GATA1 interactions | 2.27e-04 | 171 | 65 | 5 | int:GATA1 | |
| Interaction | PIN1 interactions | 2.29e-04 | 383 | 65 | 7 | int:PIN1 | |
| Interaction | KLF1 interactions | 2.30e-04 | 37 | 65 | 3 | int:KLF1 | |
| Interaction | PLSCR1 interactions | 2.33e-04 | 172 | 65 | 5 | int:PLSCR1 | |
| Interaction | SNRPF interactions | 2.36e-04 | 385 | 65 | 7 | int:SNRPF | |
| Interaction | PRDM14 interactions | 2.52e-04 | 95 | 65 | 4 | int:PRDM14 | |
| Interaction | RAD54L2 interactions | 2.52e-04 | 95 | 65 | 4 | int:RAD54L2 | |
| Interaction | ARID1A interactions | 2.62e-04 | 276 | 65 | 6 | int:ARID1A | |
| Interaction | TP53BP1 interactions | 3.05e-04 | 533 | 65 | 8 | int:TP53BP1 | |
| Interaction | SMARCD2 interactions | 3.11e-04 | 183 | 65 | 5 | int:SMARCD2 | |
| Interaction | CELF1 interactions | 3.29e-04 | 288 | 65 | 6 | int:CELF1 | |
| Interaction | TLX3 interactions | 3.48e-04 | 291 | 65 | 6 | int:TLX3 | |
| Interaction | ID2 interactions | 3.69e-04 | 105 | 65 | 4 | int:ID2 | |
| Interaction | HDLBP interactions | SRRT ERBB2 DAZAP1 YLPM1 EIF4G1 SMARCA4 DIDO1 PLRG1 KHSRP CPSF7 | 3.86e-04 | 855 | 65 | 10 | int:HDLBP |
| Interaction | RBM14 interactions | 3.90e-04 | 553 | 65 | 8 | int:RBM14 | |
| Interaction | P4HA1 interactions | 3.95e-04 | 298 | 65 | 6 | int:P4HA1 | |
| Interaction | WWTR1 interactions | 4.11e-04 | 422 | 65 | 7 | int:WWTR1 | |
| Interaction | TSG101 interactions | 4.31e-04 | 303 | 65 | 6 | int:TSG101 | |
| Interaction | PAPOLB interactions | 4.53e-04 | 10 | 65 | 2 | int:PAPOLB | |
| Interaction | PPARG interactions | 4.62e-04 | 307 | 65 | 6 | int:PPARG | |
| Interaction | PLSCR3 interactions | 4.99e-04 | 48 | 65 | 3 | int:PLSCR3 | |
| Interaction | BCL7C interactions | 5.21e-04 | 115 | 65 | 4 | int:BCL7C | |
| Interaction | SNRPC interactions | 5.27e-04 | 440 | 65 | 7 | int:SNRPC | |
| Interaction | TBXT interactions | 5.38e-04 | 116 | 65 | 4 | int:TBXT | |
| Interaction | SCARNA22 interactions | 5.74e-04 | 118 | 65 | 4 | int:SCARNA22 | |
| Interaction | NFIC interactions | 5.82e-04 | 210 | 65 | 5 | int:NFIC | |
| Interaction | EED interactions | SRRT EPS8L2 DAZAP1 MYO1E SZT2 YLPM1 EIF4G1 SMARCA4 DIDO1 HNRNPUL1 ARID1A KHSRP CPSF7 | 6.14e-04 | 1445 | 65 | 13 | int:EED |
| Interaction | PAX7 interactions | 6.92e-04 | 124 | 65 | 4 | int:PAX7 | |
| Interaction | SAA1 interactions | 7.06e-04 | 54 | 65 | 3 | int:SAA1 | |
| Interaction | MKNK2 interactions | 7.45e-04 | 55 | 65 | 3 | int:MKNK2 | |
| Interaction | RUNX1T1 interactions | 7.57e-04 | 127 | 65 | 4 | int:RUNX1T1 | |
| Interaction | NCOA3 interactions | 7.79e-04 | 224 | 65 | 5 | int:NCOA3 | |
| Interaction | NKX2-4 interactions | 7.81e-04 | 13 | 65 | 2 | int:NKX2-4 | |
| Interaction | TPRX2 interactions | 7.86e-04 | 56 | 65 | 3 | int:TPRX2 | |
| Interaction | FBLN1 interactions | 8.02e-04 | 129 | 65 | 4 | int:FBLN1 | |
| Interaction | NFIX interactions | 8.27e-04 | 227 | 65 | 5 | int:NFIX | |
| Interaction | CRKL interactions | 8.27e-04 | 227 | 65 | 5 | int:CRKL | |
| Interaction | FOXC1 interactions | 8.44e-04 | 228 | 65 | 5 | int:FOXC1 | |
| Interaction | SMARCA2 interactions | 8.64e-04 | 346 | 65 | 6 | int:SMARCA2 | |
| Cytoband | 1p34.2 | 7.85e-05 | 57 | 66 | 3 | 1p34.2 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q12 | 1.32e-03 | 149 | 66 | 3 | chr17q12 | |
| GeneFamily | Paired boxes | 1.46e-06 | 9 | 48 | 3 | 675 | |
| GeneFamily | Phospholipid scramblases | 6.87e-05 | 5 | 48 | 2 | 954 | |
| GeneFamily | PRD class homeoboxes and pseudogenes | 1.03e-04 | 92 | 48 | 4 | 521 | |
| GeneFamily | LIM domain containing | 5.14e-04 | 59 | 48 | 3 | 1218 | |
| GeneFamily | AT-rich interaction domain containing | 7.09e-04 | 15 | 48 | 2 | 418 | |
| GeneFamily | TALE class homeoboxes and pseudogenes | 2.15e-03 | 26 | 48 | 2 | 526 | |
| GeneFamily | Collagens | 6.63e-03 | 46 | 48 | 2 | 490 | |
| Coexpression | GRESHOCK_CANCER_COPY_NUMBER_UP | 1.51e-06 | 323 | 66 | 8 | M9150 | |
| Coexpression | GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_DN | 2.11e-06 | 338 | 66 | 8 | M17094 | |
| Coexpression | GSE27786_CD4_VS_CD8_TCELL_UP | 1.14e-05 | 200 | 66 | 6 | M4819 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_DN | 1.14e-05 | 200 | 66 | 6 | M9654 | |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_28DY_DN | PIGQ SRRT RARA ZMIZ2 SMARCA4 C15orf39 RAPGEF1 DIDO1 PLSCR3 ZDHHC8 PLSCR1 | 1.48e-05 | 905 | 66 | 11 | M40865 |
| Coexpression | THAKAR_PBMC_INACTIVATED_INFLUENZA_AGE_21_30YO_RESPONDERS_7DY_DN | 2.90e-05 | 634 | 66 | 9 | M40866 | |
| Coexpression | VALK_AML_CLUSTER_13 | 6.52e-05 | 31 | 66 | 3 | M2603 | |
| Coexpression | TABULA_MURIS_SENIS_GONADAL_ADIPOSE_TISSUE_MESENCHYMAL_STEM_CELL_OF_ADIPOSE_AGEING | 7.74e-05 | 720 | 66 | 9 | MM3700 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_DN | COL4A3 LDB3 RARA HCN4 ZMIZ2 SMR3A C15orf39 TNXB PLSCR1 PDLIM4 | 8.69e-05 | 909 | 66 | 10 | M41018 |
| Coexpression | CAMPS_COLON_CANCER_COPY_NUMBER_UP | 9.05e-05 | 93 | 66 | 4 | M18750 | |
| Coexpression | GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN | 1.02e-04 | 184 | 66 | 5 | M19988 | |
| Coexpression | DESCARTES_FETAL_EYE_ASTROCYTES | 1.31e-04 | 39 | 66 | 3 | M40188 | |
| Coexpression | GSE3982_MEMORY_CD4_TCELL_VS_TH2_UP | 1.37e-04 | 196 | 66 | 5 | M5381 | |
| Coexpression | GSE3982_DC_VS_EFF_MEMORY_CD4_TCELL_DN | 1.40e-04 | 197 | 66 | 5 | M5475 | |
| Coexpression | GSE18281_SUBCAPSULAR_CORTICAL_REGION_VS_WHOLE_MEDULLA_THYMUS_UP | 1.47e-04 | 199 | 66 | 5 | M7254 | |
| Coexpression | GSE22103_UNSTIM_VS_LPS_STIM_NEUTROPHIL_UP | 1.51e-04 | 200 | 66 | 5 | M7794 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP | 1.51e-04 | 200 | 66 | 5 | M6207 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5|TCGA-Ovary / Sample_Type by Project: Shred V9 | 1.74e-07 | 166 | 66 | 6 | 32d2eaf8a5d03881bf74d680825af2d5110b082d | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.06e-07 | 199 | 66 | 6 | 2e7f517c0444b4f29ff11c26ab32e9cc0f7e99ef | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-06 | 145 | 66 | 5 | 8da10bc6611976e1ec85e09f04a2dc5bf6555c9e | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.02e-06 | 151 | 66 | 5 | 16fc903fc71e25717b9908416f0bcd29c0a65a61 | |
| ToppCell | Immune_cells-B_cell|Immune_cells / Lineage and Cell class | 5.70e-06 | 172 | 66 | 5 | b646894b691a99bf2742bd9da8e578dff0e87f1f | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 174 | 66 | 5 | 2f4bc0275cbcaa830d04a4c76e042456908d2277 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 174 | 66 | 5 | 01eff218e71a04201189a0313aaf91437fffed95 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.03e-06 | 174 | 66 | 5 | f0f6d135e1fb4c15022be103b00d8d5456515a18 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells-IgA_plasma_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.50e-06 | 182 | 66 | 5 | 626aabfd9ac662c1d189f7c4b660482914d9e669 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-Plasma_cells|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.50e-06 | 182 | 66 | 5 | a00abff41c12b71d5860c494b8c722d649fd5f36 | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.70e-06 | 183 | 66 | 5 | ff6dde877659cde9daa3263db0932c9c9ef1adac | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_lymph_vessel-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.70e-06 | 183 | 66 | 5 | bc98df870de65aff6dab295c24cbc199c7f2aa15 | |
| ToppCell | AT1-AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 7.70e-06 | 183 | 66 | 5 | 6821dca076318115d360ff426eb1218cfe104063 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-06 | 185 | 66 | 5 | 6da9a06e1514d5d5f47359a14637f02539846096 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.12e-06 | 185 | 66 | 5 | 4a188e2566a75d1b4f3c879a8c241c277c4b451c | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic-B_cell|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.02e-05 | 194 | 66 | 5 | ff661419b697aef51a53fdeac8d37d870d65f491 | |
| ToppCell | COVID-19-Heart-EC_1|Heart / Disease (COVID-19 only), tissue and cell type | 1.05e-05 | 195 | 66 | 5 | 50a193475db1bb1e05b8590225a553688c372c14 | |
| ToppCell | Smart-seq2-lymph_node_(Smart-seq2)-lymphocytic-B_lymphocytic|lymph_node_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.10e-05 | 197 | 66 | 5 | fa3cc33c975648172feabb485c3bdd087f1f8ea7 | |
| ToppCell | COVID-19-kidney-AQP1+PLVAP+EC|kidney / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 198 | 66 | 5 | 8689090bce9ab6e8f122426a404037e572c6713b | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell-Connecting_Tubule_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 199 | 66 | 5 | 3cd6383c50ce342fe5c175e2e50784d634a90e80 | |
| ToppCell | LPS_anti-TNF-Epithelial_alveolar-AT_1|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 1.18e-05 | 200 | 66 | 5 | 8683445ad5b70748c4a1f12eb77d47623085147e | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-05 | 200 | 66 | 5 | 8954553c05849f3cd591ec663d9caeff2035e168 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Macroglial|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 1.18e-05 | 200 | 66 | 5 | be1abe5bb1ce4e7dfec63af4ed0fc5b96bf77866 | |
| ToppCell | 3'-GW_trimst-2-SmallIntestine-Epithelial-epithelial_progenitor_cell-Proximal_progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.91e-05 | 158 | 66 | 4 | 2ae863ccef201414b82a2ecf7cf1bbb1b0ce4a3c | |
| ToppCell | Immune_cells-B_cell|World / Lineage and Cell class | 1.00e-04 | 163 | 66 | 4 | 3a02465de7c2f7cea227e289fb082a1fb6400301 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 164 | 66 | 4 | cdb8cd2d6b369189ea77e4946738e2816d502e03 | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 164 | 66 | 4 | 5dbfcdd450f652b16d97da53b528d4584b0eabcf | |
| ToppCell | facs-Trachea-18m-Epithelial-glandular_epithelial-lung_secretory_cell-mucous|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.03e-04 | 164 | 66 | 4 | f1423f4434af4af9c60c8a5b0b0abec4a7df9401 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 170 | 66 | 4 | 928e42c51a7079c506f21c669c4e4c1a0df84d77 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.18e-04 | 170 | 66 | 4 | 5d5f208682be21ed58320f5fc083a7898f8712da | |
| ToppCell | droplet-Pancreas-Exocrine|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 171 | 66 | 4 | 92ac4cc3d54da2ea8e202aa59c78e8875356649e | |
| ToppCell | AT1_cells-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 1.35e-04 | 176 | 66 | 4 | 4a30bb771297b30926fb98e2b5ec0dbdc46feac7 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 177 | 66 | 4 | 8dfadd9852e0c256363471a7cfe6af120c8c51e0 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 177 | 66 | 4 | 767b2af5f224d100b22bed32f86cec1cd17e8711 | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 177 | 66 | 4 | 5ef2527e9b41e62f1724cdabaad9d8979266bb7d | |
| ToppCell | E18.5-Endothelial-Endothelial_lymphatic|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.38e-04 | 177 | 66 | 4 | ae1d2fdd4f67f50c906b27ea084de058c6908aa2 | |
| ToppCell | mild_COVID-19_(asymptomatic)-B_memory|World / disease group, cell group and cell class (v2) | 1.38e-04 | 177 | 66 | 4 | 057871e211c6508b2a679d391f3cf0ac7ccfc628 | |
| ToppCell | IIH-CD8-antiviral_CD4|IIH / Condition, Cell_class and T cell subcluster | 1.38e-04 | 177 | 66 | 4 | fe73608c40701eca88b260aeb5c0640d7bee72ba | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_1_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 1.44e-04 | 179 | 66 | 4 | d5763912a4ce7188535675e338799b856edb9dda | |
| ToppCell | AT1_cells-Cryobiopsy_01|World / lung cells shred on cell class, cell subclass, sample id | 1.44e-04 | 179 | 66 | 4 | 1603117b52623663458a977c94bf7f9f6c1114b8 | |
| ToppCell | COVID-19-Heart-EC_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.44e-04 | 179 | 66 | 4 | 2a53d94f6c30bf887dfe88f1693ea057218c852d | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.50e-04 | 181 | 66 | 4 | a8e9ea73c24109a5d4d28bc0577cc869ad932a4d | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.50e-04 | 181 | 66 | 4 | b45b11428d13950369347e051d4d517efb2bd4fd | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-04 | 181 | 66 | 4 | 071f9bb5d39070cdc473d9b0e094d196bc702b56 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response-SM_activated_stress_response_L.2.3.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 182 | 66 | 4 | 97bb07478f56a937b490fba121ee603db64134a1 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-SM_activated_stress_response|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.54e-04 | 182 | 66 | 4 | 1c1a687f728341c209b048b6715bcddd0ac20069 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 183 | 66 | 4 | 0513bb73552bfee609877d924fa97684200f595c | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 183 | 66 | 4 | 6eeef55071ae25a61616df4fcfb2cea560aa7923 | |
| ToppCell | facs-Thymus-Flowthrough-24m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.57e-04 | 183 | 66 | 4 | 85b2335fa938a94e74251bd8d99de1bd21265ac9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.57e-04 | 183 | 66 | 4 | 93213124e55d1b673dd345188caf8b5bd31d99fe | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.60e-04 | 184 | 66 | 4 | f6d6b3ddada66dae28d3306415bf4efe0934208a | |
| ToppCell | (2)_5-FU-(4)_COL2.3+_osteoblasts|World / Stress and Cell class | 1.60e-04 | 184 | 66 | 4 | 684d05340a3dfb8aa08b881516a37f9627a10448 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 184 | 66 | 4 | cb15d6bae52c5ec251c2235859dc7e65f630ae23 | |
| ToppCell | 343B-Epithelial_cells-Epithelial-I_(AT1)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 1.60e-04 | 184 | 66 | 4 | bde4eaabd3e9bdaed23867d23a919b9d84b52d4b | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.60e-04 | 184 | 66 | 4 | b12fb85a064f715a4f0ada1df8e422c359b573cf | |
| ToppCell | LPS-antiTNF-Epithelial_alveolar-AT_1-AT1-AT2|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-04 | 185 | 66 | 4 | 3bef59cc0aa939d2a7e52f0f6c61bc00528fe50b | |
| ToppCell | Endothelial-A-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-04 | 185 | 66 | 4 | ae49c61f6ecf128fe2a958b8c75c83688da75f59 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.63e-04 | 185 | 66 | 4 | c82eab551f65ecebe6db908eda9f9eb3414693c7 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.63e-04 | 185 | 66 | 4 | 602536a3308a848f106adcb0a83530997440c8f4 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.67e-04 | 186 | 66 | 4 | bd1185592aedebccd1007dbf2dd2f549fcdf9f42 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_1-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.67e-04 | 186 | 66 | 4 | 3aebe163799109ffc67e4e10ee47c2dd0886a92c | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.67e-04 | 186 | 66 | 4 | f07e0c0d9c80ac9d8d679950e7d0c812becb85a3 | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial-epi-tip_early|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 187 | 66 | 4 | 5f9696097741b6e2b7b410c15c6b5ed883ed5eb2 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-04 | 187 | 66 | 4 | f0de86ef25e344d9b1860ee26308877d6c25ed31 | |
| ToppCell | AT1_cells-SSc-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 1.70e-04 | 187 | 66 | 4 | f1dda349335e08dbfc8395d373924037f5ad2fd6 | |
| ToppCell | COVID-19-Heart-EC_2|Heart / Disease (COVID-19 only), tissue and cell type | 1.70e-04 | 187 | 66 | 4 | 40ffc06a3e3251d9b12da390210d3e045af7537a | |
| ToppCell | facs-Aorta-Heart-3m-Endothelial-nan|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.70e-04 | 187 | 66 | 4 | df0279b7e94e26f5541b0e2a0ce56befa96ec8ca | |
| ToppCell | wk_08-11-Epithelial-Distal_epithelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.70e-04 | 187 | 66 | 4 | eefffc2c6f7fa708a96e6bf07c6ce4e6c2e90847 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.74e-04 | 188 | 66 | 4 | 14072d0b82df55711d5356b2209f4f0bdd90dc27 | |
| ToppCell | COVID-19-kidney-DCT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.74e-04 | 188 | 66 | 4 | 1d56cd409793f05cca20757ab26e91f1a1ee67b5 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.74e-04 | 188 | 66 | 4 | c2c51c6526defe2600302901159b8abbb58d7595 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 189 | 66 | 4 | 70eea8c94fa56bb15bee8065de47acea156794e9 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 189 | 66 | 4 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_OPALIN|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.77e-04 | 189 | 66 | 4 | b60c8a29d3169c4830fe63b01db90c57660fc239 | |
| ToppCell | COVID-19-Heart-EC_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.77e-04 | 189 | 66 | 4 | fe49852ba15f948b384d6b4c258927c70b741357 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 189 | 66 | 4 | aadb7a2de4cbe7f0958651f2739bba430b93f5c1 | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.77e-04 | 189 | 66 | 4 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.77e-04 | 189 | 66 | 4 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | CTRL-Lymphoid-B_cell|Lymphoid / Disease state, Lineage and Cell class | 1.77e-04 | 189 | 66 | 4 | 14f3a8c0f4f057ad4e6839b4c3eeaf956d6dc92e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.77e-04 | 189 | 66 | 4 | 8977f3295b7df7c7474b3f371de90a82ae4bb50c | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 190 | 66 | 4 | b855b8b7d3439023390ca44629c1a99f5d4c6801 | |
| ToppCell | MS-CD8-antiviral_CD4|MS / Condition, Cell_class and T cell subcluster | 1.81e-04 | 190 | 66 | 4 | 8c831c4560b8e70f92b4c15644fea39f7f7afcf2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 190 | 66 | 4 | 59bbbd2c8d4b7ce46c54ca8022b1557e7e5eee2a | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 190 | 66 | 4 | 6b101359f397020a21e2bfd15851cb48e71f4502 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Non-neuronal-Macroglial-Oligo-Oligodendrocyte-Oligo_L4-6_MOBP_COL18A1|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.81e-04 | 190 | 66 | 4 | 396b7225c2430db3dc55a3d0db70239b71987229 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Cortical_Collecting_Duct_Principal_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.81e-04 | 190 | 66 | 4 | 078f4be52fa4cc8dd9c8d7a2b6d9631c3d902285 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 191 | 66 | 4 | a6c57627077fa980b7ec1d3894b5f31bfb11b738 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 191 | 66 | 4 | b2c86cde341fe350143658c8a8a4a9edbce3f19b | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 1.85e-04 | 191 | 66 | 4 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 191 | 66 | 4 | d0e9afe7b6334dd515d3e68892efdc76347a55e5 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_mesothelial_(19)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.85e-04 | 191 | 66 | 4 | 4c4eb61e6179d2f8fc524d2f813db9cba84f67a2 | |
| ToppCell | LAM-Epithelial-AT1|LAM / Condition, Lineage and Cell class | 1.85e-04 | 191 | 66 | 4 | 66875b2ec2c510489407f3e433a90cdf74a15094 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-04 | 191 | 66 | 4 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.85e-04 | 191 | 66 | 4 | 8f6d592edc32fdb901af30501d4360512334e8c2 | |
| ToppCell | COVID-19-kidney-CNT|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.88e-04 | 192 | 66 | 4 | 760c6b9628de9693034b00c5025c5c4df94bb2e8 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.88e-04 | 192 | 66 | 4 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 192 | 66 | 4 | 6c106b91e46eabbe686a52a65a9c94ad9cbe9390 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.88e-04 | 192 | 66 | 4 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.88e-04 | 192 | 66 | 4 | 3259cb89d6bcf0a3c6ff1f64d85e8a1f54124e91 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B-Memory_B_cells|GI_large-bowel / Manually curated celltypes from each tissue | 1.88e-04 | 192 | 66 | 4 | 31f7245bce79969674a775ecf175e7c6af68b503 | |
| Computational | Genes in the cancer module 257. | 4.33e-05 | 156 | 45 | 6 | MODULE_257 | |
| Drug | Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; HL60; HT_HG-U133A | 5.44e-09 | 200 | 65 | 9 | 2395_UP | |
| Drug | Hycanthone [3105-97-3]; Up 200; 11.2uM; PC3; HT_HG-U133A | 8.67e-08 | 196 | 65 | 8 | 4630_UP | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 9.02e-08 | 197 | 65 | 8 | 5638_UP | |
| Drug | 6-Furfurylaminopurine [525-79-1]; Down 200; 18.6uM; PC3; HT_HG-U133A | 9.02e-08 | 197 | 65 | 8 | 4477_DN | |
| Drug | Bemegride [64-65-3]; Up 200; 25.8uM; PC3; HT_HG-U133A | 9.75e-08 | 199 | 65 | 8 | 6668_UP | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.17e-06 | 190 | 65 | 7 | 4274_UP | |
| Drug | 17-AAG; Down 200; 1uM; ssMCF7; HG-U133A | 1.21e-06 | 191 | 65 | 7 | 521_DN | |
| Drug | Bretylium tosylate [61-75-6]; Down 200; 9.6uM; HL60; HT_HG-U133A | 1.30e-06 | 193 | 65 | 7 | 3057_DN | |
| Drug | Cinchonine [118-10-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.34e-06 | 194 | 65 | 7 | 3988_DN | |
| Drug | Resveratrol [501-36-0]; Up 200; 17.6uM; MCF7; HT_HG-U133A | 1.39e-06 | 195 | 65 | 7 | 2865_UP | |
| Drug | ionomycin calcium salt; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 1.39e-06 | 195 | 65 | 7 | 871_UP | |
| Drug | CP-320650-01 [172079-28-6]; Down 200; 1uM; PC3; HT_HG-U133A | 1.44e-06 | 196 | 65 | 7 | 4560_DN | |
| Drug | genistein; Up 200; 10uM; HL60; HT_HG-U133A | 1.44e-06 | 196 | 65 | 7 | 6194_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | 1.49e-06 | 197 | 65 | 7 | 4266_UP | |
| Drug | Gossypol [303-45-7]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 1.54e-06 | 198 | 65 | 7 | 4762_DN | |
| Drug | Tolnaftate [2398-96-1]; Down 200; 13uM; MCF7; HT_HG-U133A | 1.54e-06 | 198 | 65 | 7 | 4805_DN | |
| Drug | Mesoridazine besylate [32672-69-8]; Up 200; 7.4uM; MCF7; HT_HG-U133A | 1.54e-06 | 198 | 65 | 7 | 2874_UP | |
| Drug | Nifenazone [2139-47-1]; Up 200; 13uM; MCF7; HT_HG-U133A | 1.54e-06 | 198 | 65 | 7 | 2285_UP | |
| Drug | Hydrastinine hydrochloride [4884-68-8]; Up 200; 16.4uM; PC3; HT_HG-U133A | 1.54e-06 | 198 | 65 | 7 | 5075_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.59e-06 | 199 | 65 | 7 | 3606_UP | |
| Drug | Eserine sulfate, physostigmine sulfate [64-47-1]; Up 200; 6.2uM; PC3; HT_HG-U133A | 1.59e-06 | 199 | 65 | 7 | 5749_UP | |
| Drug | Carbarsone [121-59-5]; Down 200; 15.4uM; PC3; HT_HG-U133A | 1.64e-06 | 200 | 65 | 7 | 3991_DN | |
| Drug | fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HT_HG-U133A | 1.76e-05 | 191 | 65 | 6 | 5234_DN | |
| Drug | Beta-Escin [11072-93-8]; Down 200; 3.2uM; MCF7; HT_HG-U133A | 1.76e-05 | 191 | 65 | 6 | 3890_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 1.82e-05 | 192 | 65 | 6 | 5222_DN | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; MCF7; HT_HG-U133A | 1.93e-05 | 194 | 65 | 6 | 4738_DN | |
| Drug | Cholecalciferol [67-97-0]; Down 200; 10.4uM; PC3; HT_HG-U133A | 1.93e-05 | 194 | 65 | 6 | 6656_DN | |
| Drug | Isocorydine (+) [475-67-2]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.93e-05 | 194 | 65 | 6 | 2780_UP | |
| Drug | Bepridil hydrochloride [74764-40-2]; Up 200; 10uM; HL60; HT_HG-U133A | 1.93e-05 | 194 | 65 | 6 | 1274_UP | |
| Drug | Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 1.98e-05 | 195 | 65 | 6 | 6059_DN | |
| Drug | arachidonyl trifluoromethyl ketone; Up 200; 10uM; MCF7; HG-U133A | 1.98e-05 | 195 | 65 | 6 | 327_UP | |
| Drug | Flumethasone [2135-17-3]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.98e-05 | 195 | 65 | 6 | 4272_UP | |
| Drug | Clofazimine [2030-63-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 5277_UP | |
| Drug | Salbutamol [18559-94-9]; Down 200; 16.8uM; HL60; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 2344_DN | |
| Drug | Retinoic acid [302-79-4]; Up 200; 13.4uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 5767_UP | |
| Drug | Ritodrine hydrochloride [23239-51-2]; Down 200; 12.4uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 4619_DN | |
| Drug | Heliotrine [303-33-3]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 4739_DN | |
| Drug | haloperidol; Up 200; 10uM; MCF7; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 6923_UP | |
| Drug | 0173570-0000 [211245-44-2]; Down 200; 1uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 7391_DN | |
| Drug | Pempidine tartrate [546-48-5]; Up 200; 13uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 4307_UP | |
| Drug | Oxprenolol hydrochloride [6452-73-9]; Up 200; 13.2uM; MCF7; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 7225_UP | |
| Drug | Trifluoperazine dihydrochloride [440-17-5]; Up 200; 8.4uM; HL60; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 2389_UP | |
| Drug | Graveoline [485-61-0]; Down 200; 14.4uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 4276_DN | |
| Drug | 0393-0188; Down 200; 10uM; MCF7; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 7531_DN | |
| Drug | Chloroquine diphosphate [50-63-5]; Up 200; 7.8uM; PC3; HT_HG-U133A | 2.04e-05 | 196 | 65 | 6 | 7251_UP | |
| Drug | Foliosidine [2520-38-9]; Down 200; 13uM; MCF7; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 4761_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 6167_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 4751_DN | |
| Drug | Methantheline bromide [53-46-3]; Up 200; 9.6uM; HL60; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 6137_UP | |
| Drug | Myosmine [532-12-7]; Up 200; 27.4uM; MCF7; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 6055_UP | |
| Drug | Crotamiton [483-63-6]; Up 200; 19.6uM; MCF7; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 3388_UP | |
| Drug | Butoconazole nitrate [32872-77-1]; Up 200; 8.4uM; HL60; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 2427_UP | |
| Drug | Proglumide [6620-60-6]; Down 200; 12uM; PC3; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 4337_DN | |
| Drug | Vigabatrin [60643-86-9]; Up 200; 31uM; PC3; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 6314_UP | |
| Drug | Ricinine [524-40-3]; Up 200; 24.4uM; PC3; HT_HG-U133A | 2.10e-05 | 197 | 65 | 6 | 5725_UP | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 6023_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 5904_DN | |
| Drug | Methimazole [60-56-0]; Down 200; 35uM; MCF7; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 3898_DN | |
| Drug | 16, 16-dimethylprostaglandin E2 methyl acetate solution; Down 200; 10uM; PC3; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 6592_DN | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; MCF7; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 7437_UP | |
| Drug | Theophylline monohydrate [5967-84-0]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 3326_UP | |
| Drug | Atropine sulfate monohydrate [5908-99-6]; Up 200; 5.8uM; PC3; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 5865_UP | |
| Drug | Ondansetron Hydrochloride [103639-04-9]; Down 200; 12.2uM; HL60; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 6153_DN | |
| Drug | Ethoxyquin [91-53-2]; Up 200; 18.4uM; HL60; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 2559_UP | |
| Drug | (1-[(4-Chlorophenyl)phenyl-methyl]-4-methylpiperazine) [1620-21-9]; Up 200; 11.8uM; HL60; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 2197_UP | |
| Drug | U-62066 [87151-85-7]; Down 200; 1uM; MCF7; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 3901_DN | |
| Drug | Bisoprolol fumarate; Up 200; 9uM; PC3; HT_HG-U133A | 2.16e-05 | 198 | 65 | 6 | 6748_UP | |
| Drug | Norcyclobenzaprine [303-50-4]; Up 200; 15.4uM; HL60; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 2469_UP | |
| Drug | Trapidil [15421-84-8]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 6515_UP | |
| Drug | (-) -Levobunolol hydrochloride [27912-14-7]; Down 200; 12.2uM; PC3; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 4016_DN | |
| Drug | Zuclopenthixol hydrochloride [633-59-0]; Down 200; 9.2uM; MCF7; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 4843_DN | |
| Drug | PHA-00846566E [724718-26-7]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 7081_UP | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; HL60; HG-U133A | 2.22e-05 | 199 | 65 | 6 | 1588_DN | |
| Drug | Theophylline monohydrate [5967-84-0]; Down 200; 20.2uM; PC3; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 4228_DN | |
| Drug | Brompheniramine maleate [980-71-2]; Down 200; 9.2uM; PC3; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 4013_DN | |
| Drug | 0317956-0000 [391210-11-0]; Up 200; 1uM; PC3; HT_HG-U133A | 2.22e-05 | 199 | 65 | 6 | 3777_UP | |
| Drug | Tinidazole [19387-91-8]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 2.29e-05 | 200 | 65 | 6 | 3896_DN | |
| Drug | Nifenazone [2139-47-1]; Up 200; 13uM; MCF7; HT_HG-U133A | 2.29e-05 | 200 | 65 | 6 | 6016_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Up 200; 8uM; HL60; HT_HG-U133A | 2.29e-05 | 200 | 65 | 6 | 6128_UP | |
| Drug | acebutolol | 3.29e-05 | 22 | 65 | 3 | CID000001978 | |
| Drug | 6-sulfatoxymelatonin | 7.70e-05 | 29 | 65 | 3 | CID000065096 | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 1.19e-04 | 168 | 65 | 5 | 6820_DN | |
| Drug | trichostatin A, Streptomyces sp.; Down 200; 1uM; MCF7; HT_HG-U133A | 1.33e-04 | 172 | 65 | 5 | 5903_DN | |
| Drug | 2-naphthalenesulfonate | 1.40e-04 | 92 | 65 | 4 | CID000008420 | |
| Drug | 17-AAG; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 1.44e-04 | 175 | 65 | 5 | 1006_UP | |
| Drug | Apigenin [520-36-5]; Up 200; 14.8uM; HL60; HT_HG-U133A | 1.56e-04 | 178 | 65 | 5 | 1321_UP | |
| Drug | Thioridazine hydrochloride [130-61-0]; Up 200; 9.8uM; PC3; HT_HG-U133A | 1.60e-04 | 179 | 65 | 5 | 4085_UP | |
| Drug | trichostatin A; Down 200; 0.1uM; MCF7; HG-U133A | 1.60e-04 | 179 | 65 | 5 | 331_DN | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.82e-04 | 184 | 65 | 5 | 1064_DN | |
| Drug | retinoic acid; Up 200; 1uM; MCF7; HT_HG-U133A | 1.87e-04 | 185 | 65 | 5 | 6931_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.91e-04 | 186 | 65 | 5 | 916_DN | |
| Drug | Thiostrepton [1393-48-2]; Up 200; 2.4uM; MCF7; HT_HG-U133A | 2.01e-04 | 188 | 65 | 5 | 4385_UP | |
| Drug | Niflumic acid [4394-00-7]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 2.01e-04 | 188 | 65 | 5 | 5490_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HT_HG-U133A | 2.06e-04 | 189 | 65 | 5 | 1651_DN | |
| Drug | Ethisterone [434-03-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | 2.11e-04 | 190 | 65 | 5 | 4340_DN | |
| Drug | 16-phenyl tetranor Prostaglandin E2; Up 200; 10uM; PC3; HT_HG-U133A | 2.11e-04 | 190 | 65 | 5 | 7546_UP | |
| Drug | PNU-0230031 [267429-39-0]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.11e-04 | 190 | 65 | 5 | 3629_UP | |
| Drug | Thioguanosine [85-31-4]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.11e-04 | 190 | 65 | 5 | 2619_UP | |
| Drug | ICI182,780; Down 200; 1uM; MCF7; HT_HG-U133A | 2.11e-04 | 190 | 65 | 5 | 5926_DN | |
| Drug | valinomycin; Down 200; 0.1uM; MCF7; HT_HG-U133A | 2.17e-04 | 191 | 65 | 5 | 5957_DN | |
| Disease | MENTAL RETARDATION, AUTOSOMAL DOMINANT 12 | 1.02e-07 | 5 | 65 | 3 | C3281201 | |
| Disease | Coffin-Siris syndrome | 2.87e-06 | 13 | 65 | 3 | C0265338 | |
| Disease | primary angle-closure glaucoma (is_implicated_in) | 1.43e-05 | 3 | 65 | 2 | DOID:1405 (is_implicated_in) | |
| Disease | NEPHROTIC SYNDROME, STEROID-RESISTANT, AUTOSOMAL RECESSIVE | 3.97e-05 | 30 | 65 | 3 | C1868672 | |
| Disease | Burkitt Lymphoma | 6.92e-05 | 36 | 65 | 3 | C0006413 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 7.17e-05 | 195 | 65 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | Neoplasm of uncertain or unknown behavior of breast | 1.02e-04 | 41 | 65 | 3 | C0496956 | |
| Disease | Breast adenocarcinoma | 1.02e-04 | 41 | 65 | 3 | C0858252 | |
| Disease | myopathy (implicated_via_orthology) | 1.64e-04 | 48 | 65 | 3 | DOID:423 (implicated_via_orthology) | |
| Disease | Focal segmental glomerulosclerosis | 2.13e-04 | 10 | 65 | 2 | cv:C0017668 | |
| Disease | Inherited focal segmental glomerulosclerosis | 2.13e-04 | 10 | 65 | 2 | cv:CN327126 | |
| Disease | neuroblastoma (is_implicated_in) | 2.13e-04 | 10 | 65 | 2 | DOID:769 (is_implicated_in) | |
| Disease | Small cell carcinoma of lung | 2.34e-04 | 54 | 65 | 3 | C0149925 | |
| Disease | Hereditary Nephrotic Syndromes, Autosomal Dominant | 2.59e-04 | 11 | 65 | 2 | cv:CN043612 | |
| Disease | level of Sphingomyelin (d34:2) in blood serum | 3.67e-04 | 13 | 65 | 2 | OBA_2045174 | |
| Disease | Familial idiopathic steroid-resistant nephrotic syndrome | 3.67e-04 | 13 | 65 | 2 | cv:C4273714 | |
| Disease | Burkitt Leukemia | 4.93e-04 | 15 | 65 | 2 | C4721444 | |
| Disease | African Burkitt's lymphoma | 4.93e-04 | 15 | 65 | 2 | C0343640 | |
| Disease | cardiomyopathy (implicated_via_orthology) | 5.24e-04 | 71 | 65 | 3 | DOID:0050700 (implicated_via_orthology) | |
| Disease | sexual dimorphism measurement | 6.85e-04 | 1106 | 65 | 9 | EFO_0021796 | |
| Disease | level of Phosphatidylethanolamine (18:0_20:4) in blood serum | 7.98e-04 | 19 | 65 | 2 | OBA_2045140 | |
| Disease | corneal hysteresis | 8.85e-04 | 20 | 65 | 2 | EFO_0010066 | |
| Disease | intraocular pressure measurement | 8.94e-04 | 509 | 65 | 6 | EFO_0004695 | |
| Disease | Anophthalmia-microphthalmia syndrome | 9.77e-04 | 21 | 65 | 2 | cv:C5680330 | |
| Disease | Nasopharyngeal carcinoma | 1.07e-03 | 22 | 65 | 2 | C2931822 | |
| Disease | triacylglycerol 58:9 measurement | 1.07e-03 | 22 | 65 | 2 | EFO_0010443 | |
| Disease | Neurodevelopmental Disorders | 1.15e-03 | 93 | 65 | 3 | C1535926 | |
| Disease | Renal glomerular disease | 1.17e-03 | 23 | 65 | 2 | C0268731 | |
| Disease | Glomerulopathy Assessment | 1.17e-03 | 23 | 65 | 2 | C4521256 | |
| Disease | Intrahepatic Cholangiocarcinoma | 1.28e-03 | 24 | 65 | 2 | C0345905 | |
| Disease | Extrahepatic Cholangiocarcinoma | 1.28e-03 | 24 | 65 | 2 | C3805278 | |
| Disease | Cholangiocarcinoma | 1.50e-03 | 26 | 65 | 2 | C0206698 | |
| Disease | Sezary Syndrome | 1.62e-03 | 27 | 65 | 2 | C0036920 | |
| Disease | docosapentaenoic acid measurement | 1.62e-03 | 27 | 65 | 2 | EFO_0006809 | |
| Disease | Hyalinosis, Segmental Glomerular | 1.74e-03 | 28 | 65 | 2 | C0086432 | |
| Disease | corneal topography | 1.81e-03 | 109 | 65 | 3 | EFO_0004345 | |
| Disease | Epilepsy | 1.81e-03 | 109 | 65 | 3 | C0014544 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 1.87e-03 | 29 | 65 | 2 | C0496920 | |
| Disease | coronary artery disease, factor VII measurement | 1.91e-03 | 111 | 65 | 3 | EFO_0001645, EFO_0004619 | |
| Disease | Ovarian Carcinoma | 2.00e-03 | 30 | 65 | 2 | C0029925 | |
| Disease | factor VIII measurement, coronary artery disease | 2.01e-03 | 113 | 65 | 3 | EFO_0001645, EFO_0004630 | |
| Disease | factor XI measurement, coronary artery disease | 2.11e-03 | 115 | 65 | 3 | EFO_0001645, EFO_0004694 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| YLTPQGGAAPQPHPP | 1196 | P04626 | |
| ANGPVPGPYGLPPQA | 771 | P55198 | |
| LPPPPPVTYQVGYGH | 666 | O60583 | |
| ELGQPPGLYPSSHPP | 471 | Q02641 | |
| YIPGPPGLPGLPGLH | 481 | Q01955 | |
| GAPPPHPQLYPGGTG | 211 | P54259 | |
| PPSGQPPYGGHQPGL | 1421 | Q8NFD5 | |
| VEPRGYLGPPHQGPP | 341 | P33240 | |
| PSQQPPSYGGPSVPG | 366 | Q96EP5 | |
| GHGQPLPPGFPSPFL | 596 | Q9UI36 | |
| QPLGGPEPGPYAQPS | 211 | P46108 | |
| LPGYPPHIPTSGQGS | 371 | Q06710 | |
| PGGGHLNGYPVPPYA | 11 | P10276 | |
| SFGVPPPPPGIHYQH | 251 | Q8N684 | |
| YPAGAPAPGPHPAAG | 291 | P78411 | |
| GPGPHYLSGPLPPGT | 781 | Q9H3S7 | |
| FPGPFCPQALGHPPG | 606 | O60393 | |
| TLPGYPPHVPPAGQG | 311 | Q02548 | |
| PPHVPPAGQGSYSAP | 316 | Q02548 | |
| MHGQPGIPPYGTLPP | 841 | O14497 | |
| PSHGTRQPPYGPSAP | 1546 | O14497 | |
| PEPPPPLSVYHNGTG | 1161 | Q8WXD9 | |
| RGGPAYTPAGPQVPP | 516 | O75112 | |
| GLSYQPNGLPHPTPP | 281 | Q06455 | |
| GPVPGPQHYTLGRPG | 1326 | Q5JU85 | |
| GTHPYPPGPGVALTA | 96 | O43660 | |
| GPQVSYPPPPAGHSG | 41 | O15162 | |
| TPGYPEPALHPGPGQ | 21 | Q9NRY6 | |
| GPPGPPGTPVYDSNV | 1261 | P39060 | |
| GLHPVPGGVFPVPPA | 601 | Q12996 | |
| HPVPQPGYPGCQPLG | 61 | Q9NZ81 | |
| THPEPPLPQGPYTEG | 391 | Q96T92 | |
| PPQGPAPIPFQHRGG | 201 | Q9H6S3 | |
| GPPGRPYGAIPGQHV | 1136 | Q9Y3Q4 | |
| TTLPGYPPHVPPTGQ | 336 | Q02962 | |
| EAVPAAPGPYGPHRP | 26 | A8K0S8 | |
| PPGYPHIPQALSTPG | 566 | Q9UPW0 | |
| SPNGSIPPIHVPPGY | 71 | Q53EP0 | |
| PTGGIYPNPNVPRHP | 426 | Q01543 | |
| RTYFPGPPGDGHPEP | 926 | Q9BTC0 | |
| PIPSLFSGQHGPPPY | 1806 | Q9BTC0 | |
| PVQPGAPGFYPGASP | 121 | Q04637 | |
| HGQPIYPGPLGALPQ | 281 | Q8N9Y4 | |
| PGLQPHAEPGGYSGP | 81 | Q9BUJ2 | |
| GPPPHQYPPQGWGNT | 536 | Q92945 | |
| GPVPRPPDPVTYHGQ | 2781 | Q5T011 | |
| PGYPEPLAPGHGSPF | 411 | P19484 | |
| PGTRLPPPTHGPQEY | 1856 | Q5JRA6 | |
| PYGQPPRFPVPHNGS | 136 | P50479 | |
| PSGPGPSLPEPHGVY | 736 | Q9BRB3 | |
| SAGHPIPTQGPGGYP | 51 | P51532 | |
| GPGPAPPNYSRPHGM | 241 | P51532 | |
| PAPVPPGFGAVYGEP | 126 | O94819 | |
| PYSQPQPGIGLSPPH | 11 | O94855 | |
| AVPTGGPPYPHAPYG | 816 | Q9BXP5 | |
| YPGRAAAPPNAPGGP | 96 | Q96RK1 | |
| PLGPPCQDTGPTHYP | 256 | Q6ZRI6 | |
| THPAGVRPPIPGPPY | 226 | Q9Y3P4 | |
| LGPPFQLPLGGHPQP | 426 | Q13905 | |
| PPPYGPGRIQSHSLP | 81 | Q99954 | |
| PGRIQSHSLPPPYGP | 86 | Q99954 | |
| HGVPPGGKPSDPIIY | 1031 | P22105 | |
| GRYGGSSHYPPPPVP | 6 | P49750 | |
| LPQHGYPGPPQAQPL | 246 | Q8NF64 | |
| GQPPAPSPSYPGHRL | 296 | Q8NF64 | |
| GLQGFPRAPPPYPTH | 701 | Q96JG9 | |
| GPGGLHAAYPPSPPL | 406 | Q9ULC8 | |
| PLTPPPSYGHQPQTG | 31 | O43294 | |
| PGPIVQYPGSNAGPP | 161 | Q5SRN2 | |
| GPGLHYAPPAPPAFG | 206 | Q9Y5W3 | |
| PVRAAPPPPGYHQNG | 951 | Q12965 | |
| RHGPLPPPGYGTPLN | 86 | Q9Y2G1 |